Tanox to Report 2005 Fourth Quarter and Full Year Results Feb. 28
February 08 2006 - 9:30PM
PR Newswire (US)
HOUSTON, Feb. 8 /PRNewswire-FirstCall/ -- Tanox, Inc. (NASDAQ:TNOX)
will announce its 2005 fourth quarter and full year financial
results Feb. 28, 2006. The announcement will be made before the
opening of the financial markets, with a conference call for the
investment community to follow at 10 a.m., EST. Tanox President and
Chief Executive Officer Danong Chen, Ph.D. and Vice President of
Finance Greg Guidroz will outline results of the fourth quarter and
fiscal year 2005, provide an update on the company's operations and
outline 2006 objectives. Live audio of the conference call will be
webcast on the Internet. The webcast will be accessible on the
Tanox Web site at http://www.tanox.com/ in the Investor Relations
section. About Tanox, Inc. Tanox is a biotechnology company
specializing in the discovery and development of monoclonal
antibodies. The company develops innovative biotherapeutics for the
treatment of immune-mediated diseases, inflammation, infectious
disease and cancer. Tanox's lead investigational therapy, TNX-355,
is a viral-entry inhibitor antibody to treat HIV/AIDS. TNX-355 has
shown significant antiretroviral activity in Phase 2 clinical
testing. Tanox's first-approved drug, Xolair(R) (omalizumab), is
the first antibody approved to treat moderate-to-severe confirmed
allergic asthma. Xolair was developed in collaboration with
Genentech, Inc. and Novartis Pharma AG and is approved for
marketing in the United States, Canada and major European
countries. Tanox is based in Houston and has a manufacturing
facility in San Diego. Additional corporate information is
available at http://www.tanox.com/.
http://www.newscom.com/cgi-bin/prnh/20050207/TNOXLOGO DATASOURCE:
Tanox, Inc. CONTACT: Steve Sievert of Tanox, Inc., +1-713-578-4211,
Web site: http://www.tanox.com/
Copyright
Tanox (NASDAQ:TNOX)
Historical Stock Chart
From May 2024 to Jun 2024
Tanox (NASDAQ:TNOX)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Tanox (MM) (NASDAQ): 0 recent articles
More Tanox (MM) News Articles